
News|Articles|December 24, 2024
RECAP: 2024 Updates in the GLP-1 Space
Key Takeaways
Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
2
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
3
FDA Approves T-DXd With Pertuzumab for First-Line Treatment of Advanced HER2+Breast Cancer
4
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
5

















































































































































































































